Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Biogen wins Tecfidera U.S. patent dispute with Forward Pharma

Saturday, April 01, 2017

A US patent board on Friday ruled against Danish drugmaker Forward Pharma AS finding Biogens patents on its blockbuster multiple sclerosis drug Tecfidera to be valid The ruling by the US Patent Trial and Appeal Board PTAP frees Bigoen Inc from fut...

miRagen Therapeutics Receives Orphan-Drug Designation for MRG-106

Saturday, April 01, 2017

miRagen Therapeutics Inc a clinicalstage biopharmaceutical company focused on the discovery and development of microRNAtargeted therapies today announced that the US Food and Drug Administration FDA has granted orphandrug designation to miRagens prod...

Avillion Signs Clinical Co-development Agreement With Merck to Advance Anti IL-17 A/F Nanobody® in Psoriasis

Friday, March 31, 2017

Avillion LLP a codeveloper and financier of latestage pharmaceutical product candidates announces that it has signed a clinical codevelopment agreement with Merck Darmstadt Germany a leading science and technology company to advance Mercks anti IL AF...

Hilleman Laboratories Signs MoU With NICED, ICMR to Develop Shigella Vaccine

Friday, March 31, 2017

Hilleman Laboratories a jointventure partnership between MSD and Wellcome Trust signed a Memorandum of Understanding MoU with National Institute of Cholera and Enteric Diseases NICED an ICMR organization for further development and commercialization...

Espero Pharmaceuticals and Armetheon to Merge

Friday, March 31, 2017

Espero Pharmaceuticals Inc a privately held commercialstage cardiovascular pharmaceutical company and Armetheon Inc a privately held lateclinical stage pharmaceutical company developing innovative novel drugs addressing major unmet needs in cardiovas...

Sonoma Pharmaceuticals Receives U.S. FDA Clearance of Loyon® Skin Descaler

Thursday, March 30, 2017

Sonoma Pharmaceuticals Inc a specialty pharmaceutical company that develops and markets unique and effective solutions for the treatment of dermatological conditions and advanced tissue care today announced it has received a new k clearance from the...

Mylan Completes Acquisition of Cold-EEZE<sup>&reg;</sup> Brand

Thursday, March 30, 2017

Mylan NV today announced the successful acquisition of the global rights to the ColdEEZE brand cold remedy line from ProPhase Labs Inc The transaction provides Mylan all assets and rights relating to the ColdEEZE brand including all US businesses...

Vanda and UCSF Announce License Agreement for CFTR Activators and Inhibitors

Thursday, March 30, 2017

Vanda Pharmaceuticals Inc announced that it has entered into a license agreement with UC San Francisco UCSF under which Vanda will acquire an exclusive worldwide license from UCSF to develop and commercialize a portfolio of Cystic Fibrosis Transmembr...

Perrigo Completes Divestiture Of Tysabri® Royalty Stream For Up To $2.85 Billion

Tuesday, March 28, 2017

Perrigo Company plc a leading global provider of Quality Affordable Healthcare Products today announced it has completed the divestiture of its rights to the royalty stream from global net sales of the multiple sclerosis drug Tysabri natalizumab to R...

Orexigen Therapeutics Announces Commercialization and Distributorship Agreement with Bruno Farmaceutici S.p.A.

Tuesday, March 28, 2017

Orexigen Therapeutics Inc announced that its wholly owned subsidiary Orexigen Therapeutics Ireland Ltd and Bruno Farmaceutici SpA Bruno have executed a distributorship agreement for Mysimba naltrexone HCl bupropion HCl prolonged release in Italy Mys...